Jennifer (Ying) Lan
Lawyers
Filters
Stoke Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of 9,074,776 shares of common stock of Stoke Therapeutics, Inc.,…
Magenta Therapeutics, Inc. $64.8 Million Follow-On Offering of Common Stock
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8 million follow-on offering of common stock of Magenta Therapeutics,…
TransMedics Group, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its $250 Million Notes Reopening
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $250 million aggregate principal amount of its 4.375% senior notes due 2029. The…
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its €1.1 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. (MMC) in connection with its SEC-registered offering of €550 million aggregate principal amount of its 1.349% senior notes due 2026…
Davis Polk Advises Marsh & McLennan Companies on Its $5 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…
Davis Polk Advises S.A.C.I. Falabella on Its $550 Million Global Equity Offering
Davis Polk advised S.A.C.I. Falabella in connection with an offering by S.A.C.I. Falabella and Los Olivos Inversiones S.A., a controlling shareholder of S.A.C.I. Falabella, of 49,669,211…
Davis Polk Advises Tyson Foods on Its $900 Million Senior Notes Offerings
Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…
Zai Lab Limited $150 Million Follow-On Offering of American Depositary Shares
Davis Polk advised Zai Lab Limited in connection with its first follow-on offering of $150 million of American Depositary Shares representing 7,500,000 ordinary shares of the company. The…
Magenta Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $100 million initial public offering of common stock of Magenta…